Roni Mamluk
2019
In 2019, Roni Mamluk earned a total compensation of $698K as President and Chief Executive Officer at Ayala Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $56,940 |
|---|---|
| Salary | $248,784 |
| Stock Awards | $307,447 |
| Other | $84,843 |
| Total | $698,014 |
Mamluk received $307.4K in stock awards, accounting for 44% of the total pay in 2019.
Mamluk also received $56.9K in non-equity incentive plan, $248.8K in salary and $84.8K in other compensation.
Rankings
In 2019, Roni Mamluk's compensation ranked 10,697th out of 13,971 executives tracked by ExecPay. In other words, Mamluk earned more than 23.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,697 out of 13,971 | 23rd |
Division Manufacturing | 4,330 out of 5,701 | 24th |
Major group Chemicals And Allied Products | 1,683 out of 2,200 | 24th |
Industry group Drugs | 1,440 out of 1,886 | 24th |
Industry Biological Products, Except Diagnostic Substances | 320 out of 389 | 18th |
Source: SEC filing on April 27, 2021.
Mamluk's colleagues
We found two more compensation records of executives who worked with Roni Mamluk at Ayala Pharmaceuticals in 2019.